0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Oxaliplatin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: March 2024
|
Report Code: QYRE-Auto-5N9258
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Oxaliplatin Market Insights and Forecast to 2028
BUY CHAPTERS

Oxaliplatin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-5N9258
Report
March 2024
Pages:152
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Oxaliplatin - Market Size

The global market for Oxaliplatin was estimated to be worth US$ 897.5 million in 2023 and is forecast to a readjusted size of US$ 1641.5 million by 2030 with a CAGR of 8.9% during the forecast period 2024-2030

Oxaliplatin - Market

Oxaliplatin - Market

Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy the third stage colon cancer after resecting primary tumor completely.
In this report, only the finished drug is covered, exclude API.
Europe is the largest market with about 33% market share. Followed by Japan, accounting for about 30% revenue market share.
The key players are Sanofi-Aventis, Yakult honsha, Dr Reddy's laboratories, Sun Pharmaceutical, Teva, Fresenius Kabi, Hospira, Mylan, Jiangsu Hengrui Medicine, Nanjing Pharmaceutical Factory, Jiangsu Aosaikang Pharmaceutical, Qilu Pharmaceutical, Hisun Pharmaceutical, Lunan Pharmaceutical, Luoxin, Halfsky Pharmacy, YRPG, Hainan Jinrui Pharmaceutical, Jari Pharmaceutical, Chiatai Tianqing etc. Top 3 companies occupied about 66% revenue market share.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oxaliplatin, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Oxaliplatin by region & country, by Type, and by Application.
The Oxaliplatin market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oxaliplatin.
Market Segmentation

Scope of Oxaliplatin - Market Report

Report Metric Details
Report Name Oxaliplatin - Market
Forecasted market size in 2030 US$ 1641.5 million
CAGR 8.9%
Forecasted years 2024 - 2030
Segment by Type:
  • Mannitol
  • Glucose Solution
  • Lactose Solution
  • Others
Segment by Application
  • Colorectal Cancer
  • Stomach Cancer
  • Ovarian Cancer
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Sanofi-Aventis, Yakult honsha, Dr Reddy's laboratories, Sun Pharmaceutical, Teva, Fresenius Kabi, Hospira, Mylan, Jiangsu Hengrui Medicine, Nanjing Pharmaceutical Factory, Jiangsu Aosaikang Pharmaceutical, Qilu Pharmaceutical, Hisun Pharmaceutical, Lunan Pharmaceutical, Luoxin, Halfsky Pharmacy, YRPG, Hainan Jinrui Pharmaceutical, Jari Pharmaceutical, Chiatai Tianqing
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Oxaliplatin manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Oxaliplatin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Oxaliplatin in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Oxaliplatin - Market size in 2030?

Ans: The Oxaliplatin - Market size in 2030 will be US$ 1641.5 million.

What is the Oxaliplatin - Market share by region?

Ans: Europe is the largest market with about 33% market share. Followed by Japan, accounting for about 30% revenue market share.

What is the market share of major companies in Oxaliplatin - Market?

Ans: Top 3 companies occupied about 66% revenue market share.

Who are the main players in the Oxaliplatin - Market report?

Ans: The main players in the Oxaliplatin - Market are Sanofi-Aventis, Yakult honsha, Dr Reddy's laboratories, Sun Pharmaceutical, Teva, Fresenius Kabi, Hospira, Mylan, Jiangsu Hengrui Medicine, Nanjing Pharmaceutical Factory, Jiangsu Aosaikang Pharmaceutical, Qilu Pharmaceutical, Hisun Pharmaceutical, Lunan Pharmaceutical, Luoxin, Halfsky Pharmacy, YRPG, Hainan Jinrui Pharmaceutical, Jari Pharmaceutical, Chiatai Tianqing

What are the Application segmentation covered in the Oxaliplatin - Market report?

Ans: The Applications covered in the Oxaliplatin - Market report are Colorectal Cancer, Stomach Cancer, Ovarian Cancer, Others

What are the Type segmentation covered in the Oxaliplatin - Market report?

Ans: The Types covered in the Oxaliplatin - Market report are Mannitol, Glucose Solution, Lactose Solution, Others

1 Market Overview
1.1 Oxaliplatin Product Introduction
1.2 Global Oxaliplatin Market Size Forecast
1.3 Oxaliplatin Market Trends & Drivers
1.3.1 Oxaliplatin Industry Trends
1.3.2 Oxaliplatin Market Drivers & Opportunity
1.3.3 Oxaliplatin Market Challenges
1.3.4 Oxaliplatin Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Oxaliplatin Players Revenue Ranking (2023)
2.2 Global Oxaliplatin Revenue by Company (2019-2024)
2.3 Key Companies Oxaliplatin Manufacturing Base Distribution and Headquarters
2.4 Key Companies Oxaliplatin Product Offered
2.5 Key Companies Time to Begin Mass Production of Oxaliplatin
2.6 Oxaliplatin Market Competitive Analysis
2.6.1 Oxaliplatin Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Oxaliplatin Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oxaliplatin as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Mannitol
3.1.2 Glucose Solution
3.1.3 Lactose Solution
3.1.4 Others
3.2 Global Oxaliplatin Sales Value by Type
3.2.1 Global Oxaliplatin Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Oxaliplatin Sales Value, by Type (2019-2030)
3.2.3 Global Oxaliplatin Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Colorectal Cancer
4.1.2 Stomach Cancer
4.1.3 Ovarian Cancer
4.1.4 Others
4.2 Global Oxaliplatin Sales Value by Application
4.2.1 Global Oxaliplatin Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Oxaliplatin Sales Value, by Application (2019-2030)
4.2.3 Global Oxaliplatin Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Oxaliplatin Sales Value by Region
5.1.1 Global Oxaliplatin Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Oxaliplatin Sales Value by Region (2019-2024)
5.1.3 Global Oxaliplatin Sales Value by Region (2025-2030)
5.1.4 Global Oxaliplatin Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Oxaliplatin Sales Value, 2019-2030
5.2.2 North America Oxaliplatin Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Oxaliplatin Sales Value, 2019-2030
5.3.2 Europe Oxaliplatin Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Oxaliplatin Sales Value, 2019-2030
5.4.2 Asia Pacific Oxaliplatin Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Oxaliplatin Sales Value, 2019-2030
5.5.2 South America Oxaliplatin Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Oxaliplatin Sales Value, 2019-2030
5.6.2 Middle East & Africa Oxaliplatin Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Oxaliplatin Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Oxaliplatin Sales Value
6.3 United States
6.3.1 United States Oxaliplatin Sales Value, 2019-2030
6.3.2 United States Oxaliplatin Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Oxaliplatin Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Oxaliplatin Sales Value, 2019-2030
6.4.2 Europe Oxaliplatin Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Oxaliplatin Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Oxaliplatin Sales Value, 2019-2030
6.5.2 China Oxaliplatin Sales Value by Type (%), 2023 VS 2030
6.5.3 China Oxaliplatin Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Oxaliplatin Sales Value, 2019-2030
6.6.2 Japan Oxaliplatin Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Oxaliplatin Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Oxaliplatin Sales Value, 2019-2030
6.7.2 South Korea Oxaliplatin Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Oxaliplatin Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Oxaliplatin Sales Value, 2019-2030
6.8.2 Southeast Asia Oxaliplatin Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Oxaliplatin Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Oxaliplatin Sales Value, 2019-2030
6.9.2 India Oxaliplatin Sales Value by Type (%), 2023 VS 2030
6.9.3 India Oxaliplatin Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Sanofi-Aventis
7.1.1 Sanofi-Aventis Profile
7.1.2 Sanofi-Aventis Main Business
7.1.3 Sanofi-Aventis Oxaliplatin Products, Services and Solutions
7.1.4 Sanofi-Aventis Oxaliplatin Revenue (US$ Million) & (2019-2024)
7.1.5 Sanofi-Aventis Recent Developments
7.2 Yakult honsha
7.2.1 Yakult honsha Profile
7.2.2 Yakult honsha Main Business
7.2.3 Yakult honsha Oxaliplatin Products, Services and Solutions
7.2.4 Yakult honsha Oxaliplatin Revenue (US$ Million) & (2019-2024)
7.2.5 Yakult honsha Recent Developments
7.3 Dr Reddy's laboratories
7.3.1 Dr Reddy's laboratories Profile
7.3.2 Dr Reddy's laboratories Main Business
7.3.3 Dr Reddy's laboratories Oxaliplatin Products, Services and Solutions
7.3.4 Dr Reddy's laboratories Oxaliplatin Revenue (US$ Million) & (2019-2024)
7.3.5 Sun Pharmaceutical Recent Developments
7.4 Sun Pharmaceutical
7.4.1 Sun Pharmaceutical Profile
7.4.2 Sun Pharmaceutical Main Business
7.4.3 Sun Pharmaceutical Oxaliplatin Products, Services and Solutions
7.4.4 Sun Pharmaceutical Oxaliplatin Revenue (US$ Million) & (2019-2024)
7.4.5 Sun Pharmaceutical Recent Developments
7.5 Teva
7.5.1 Teva Profile
7.5.2 Teva Main Business
7.5.3 Teva Oxaliplatin Products, Services and Solutions
7.5.4 Teva Oxaliplatin Revenue (US$ Million) & (2019-2024)
7.5.5 Teva Recent Developments
7.6 Fresenius Kabi
7.6.1 Fresenius Kabi Profile
7.6.2 Fresenius Kabi Main Business
7.6.3 Fresenius Kabi Oxaliplatin Products, Services and Solutions
7.6.4 Fresenius Kabi Oxaliplatin Revenue (US$ Million) & (2019-2024)
7.6.5 Fresenius Kabi Recent Developments
7.7 Hospira
7.7.1 Hospira Profile
7.7.2 Hospira Main Business
7.7.3 Hospira Oxaliplatin Products, Services and Solutions
7.7.4 Hospira Oxaliplatin Revenue (US$ Million) & (2019-2024)
7.7.5 Hospira Recent Developments
7.8 Mylan
7.8.1 Mylan Profile
7.8.2 Mylan Main Business
7.8.3 Mylan Oxaliplatin Products, Services and Solutions
7.8.4 Mylan Oxaliplatin Revenue (US$ Million) & (2019-2024)
7.8.5 Mylan Recent Developments
7.9 Jiangsu Hengrui Medicine
7.9.1 Jiangsu Hengrui Medicine Profile
7.9.2 Jiangsu Hengrui Medicine Main Business
7.9.3 Jiangsu Hengrui Medicine Oxaliplatin Products, Services and Solutions
7.9.4 Jiangsu Hengrui Medicine Oxaliplatin Revenue (US$ Million) & (2019-2024)
7.9.5 Jiangsu Hengrui Medicine Recent Developments
7.10 Nanjing Pharmaceutical Factory
7.10.1 Nanjing Pharmaceutical Factory Profile
7.10.2 Nanjing Pharmaceutical Factory Main Business
7.10.3 Nanjing Pharmaceutical Factory Oxaliplatin Products, Services and Solutions
7.10.4 Nanjing Pharmaceutical Factory Oxaliplatin Revenue (US$ Million) & (2019-2024)
7.10.5 Nanjing Pharmaceutical Factory Recent Developments
7.11 Jiangsu Aosaikang Pharmaceutical
7.11.1 Jiangsu Aosaikang Pharmaceutical Profile
7.11.2 Jiangsu Aosaikang Pharmaceutical Main Business
7.11.3 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Products, Services and Solutions
7.11.4 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Revenue (US$ Million) & (2019-2024)
7.11.5 Jiangsu Aosaikang Pharmaceutical Recent Developments
7.12 Qilu Pharmaceutical
7.12.1 Qilu Pharmaceutical Profile
7.12.2 Qilu Pharmaceutical Main Business
7.12.3 Qilu Pharmaceutical Oxaliplatin Products, Services and Solutions
7.12.4 Qilu Pharmaceutical Oxaliplatin Revenue (US$ Million) & (2019-2024)
7.12.5 Qilu Pharmaceutical Recent Developments
7.13 Hisun Pharmaceutical
7.13.1 Hisun Pharmaceutical Profile
7.13.2 Hisun Pharmaceutical Main Business
7.13.3 Hisun Pharmaceutical Oxaliplatin Products, Services and Solutions
7.13.4 Hisun Pharmaceutical Oxaliplatin Revenue (US$ Million) & (2019-2024)
7.13.5 Hisun Pharmaceutical Recent Developments
7.14 Lunan Pharmaceutical
7.14.1 Lunan Pharmaceutical Profile
7.14.2 Lunan Pharmaceutical Main Business
7.14.3 Lunan Pharmaceutical Oxaliplatin Products, Services and Solutions
7.14.4 Lunan Pharmaceutical Oxaliplatin Revenue (US$ Million) & (2019-2024)
7.14.5 Lunan Pharmaceutical Recent Developments
7.15 Luoxin
7.15.1 Luoxin Profile
7.15.2 Luoxin Main Business
7.15.3 Luoxin Oxaliplatin Products, Services and Solutions
7.15.4 Luoxin Oxaliplatin Revenue (US$ Million) & (2019-2024)
7.15.5 Luoxin Recent Developments
7.16 Halfsky Pharmacy
7.16.1 Halfsky Pharmacy Profile
7.16.2 Halfsky Pharmacy Main Business
7.16.3 Halfsky Pharmacy Oxaliplatin Products, Services and Solutions
7.16.4 Halfsky Pharmacy Oxaliplatin Revenue (US$ Million) & (2019-2024)
7.16.5 Halfsky Pharmacy Recent Developments
7.17 YRPG
7.17.1 YRPG Profile
7.17.2 YRPG Main Business
7.17.3 YRPG Oxaliplatin Products, Services and Solutions
7.17.4 YRPG Oxaliplatin Revenue (US$ Million) & (2019-2024)
7.17.5 YRPG Recent Developments
7.18 Hainan Jinrui Pharmaceutical
7.18.1 Hainan Jinrui Pharmaceutical Profile
7.18.2 Hainan Jinrui Pharmaceutical Main Business
7.18.3 Hainan Jinrui Pharmaceutical Oxaliplatin Products, Services and Solutions
7.18.4 Hainan Jinrui Pharmaceutical Oxaliplatin Revenue (US$ Million) & (2019-2024)
7.18.5 Hainan Jinrui Pharmaceutical Recent Developments
7.19 Jari Pharmaceutical
7.19.1 Jari Pharmaceutical Profile
7.19.2 Jari Pharmaceutical Main Business
7.19.3 Jari Pharmaceutical Oxaliplatin Products, Services and Solutions
7.19.4 Jari Pharmaceutical Oxaliplatin Revenue (US$ Million) & (2019-2024)
7.19.5 Jari Pharmaceutical Recent Developments
7.20 Chiatai Tianqing
7.20.1 Chiatai Tianqing Profile
7.20.2 Chiatai Tianqing Main Business
7.20.3 Chiatai Tianqing Oxaliplatin Products, Services and Solutions
7.20.4 Chiatai Tianqing Oxaliplatin Revenue (US$ Million) & (2019-2024)
7.20.5 Chiatai Tianqing Recent Developments
8 Industry Chain Analysis
8.1 Oxaliplatin Industrial Chain
8.2 Oxaliplatin Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Oxaliplatin Sales Model
8.5.2 Sales Channel
8.5.3 Oxaliplatin Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Oxaliplatin Market Trends
    Table 2. Oxaliplatin Market Drivers & Opportunity
    Table 3. Oxaliplatin Market Challenges
    Table 4. Oxaliplatin Market Restraints
    Table 5. Global Oxaliplatin Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Oxaliplatin Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Oxaliplatin Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Oxaliplatin Product Type
    Table 9. Key Companies Time to Begin Mass Production of Oxaliplatin
    Table 10. Global Oxaliplatin Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oxaliplatin as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Oxaliplatin Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Oxaliplatin Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Oxaliplatin Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Oxaliplatin Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Oxaliplatin Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Oxaliplatin Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Oxaliplatin Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Oxaliplatin Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Oxaliplatin Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Oxaliplatin Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Oxaliplatin Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Oxaliplatin Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Oxaliplatin Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Oxaliplatin Sales Value by Region (2019-2024) & (%)
    Table 27. Global Oxaliplatin Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Oxaliplatin Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Oxaliplatin Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Oxaliplatin Sales Value, (2025-2030) & (US$ Million)
    Table 31. Sanofi-Aventis Basic Information List
    Table 32. Sanofi-Aventis Description and Business Overview
    Table 33. Sanofi-Aventis Oxaliplatin Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Oxaliplatin Business of Sanofi-Aventis (2019-2024)
    Table 35. Sanofi-Aventis Recent Developments
    Table 36. Yakult honsha Basic Information List
    Table 37. Yakult honsha Description and Business Overview
    Table 38. Yakult honsha Oxaliplatin Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Oxaliplatin Business of Yakult honsha (2019-2024)
    Table 40. Yakult honsha Recent Developments
    Table 41. Dr Reddy's laboratories Basic Information List
    Table 42. Dr Reddy's laboratories Description and Business Overview
    Table 43. Dr Reddy's laboratories Oxaliplatin Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Oxaliplatin Business of Dr Reddy's laboratories (2019-2024)
    Table 45. Dr Reddy's laboratories Recent Developments
    Table 46. Sun Pharmaceutical Basic Information List
    Table 47. Sun Pharmaceutical Description and Business Overview
    Table 48. Sun Pharmaceutical Oxaliplatin Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Oxaliplatin Business of Sun Pharmaceutical (2019-2024)
    Table 50. Sun Pharmaceutical Recent Developments
    Table 51. Teva Basic Information List
    Table 52. Teva Description and Business Overview
    Table 53. Teva Oxaliplatin Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Oxaliplatin Business of Teva (2019-2024)
    Table 55. Teva Recent Developments
    Table 56. Fresenius Kabi Basic Information List
    Table 57. Fresenius Kabi Description and Business Overview
    Table 58. Fresenius Kabi Oxaliplatin Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Oxaliplatin Business of Fresenius Kabi (2019-2024)
    Table 60. Fresenius Kabi Recent Developments
    Table 61. Hospira Basic Information List
    Table 62. Hospira Description and Business Overview
    Table 63. Hospira Oxaliplatin Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Oxaliplatin Business of Hospira (2019-2024)
    Table 65. Hospira Recent Developments
    Table 66. Mylan Basic Information List
    Table 67. Mylan Description and Business Overview
    Table 68. Mylan Oxaliplatin Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Oxaliplatin Business of Mylan (2019-2024)
    Table 70. Mylan Recent Developments
    Table 71. Jiangsu Hengrui Medicine Basic Information List
    Table 72. Jiangsu Hengrui Medicine Description and Business Overview
    Table 73. Jiangsu Hengrui Medicine Oxaliplatin Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Oxaliplatin Business of Jiangsu Hengrui Medicine (2019-2024)
    Table 75. Jiangsu Hengrui Medicine Recent Developments
    Table 76. Nanjing Pharmaceutical Factory Basic Information List
    Table 77. Nanjing Pharmaceutical Factory Description and Business Overview
    Table 78. Nanjing Pharmaceutical Factory Oxaliplatin Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Oxaliplatin Business of Nanjing Pharmaceutical Factory (2019-2024)
    Table 80. Nanjing Pharmaceutical Factory Recent Developments
    Table 81. Jiangsu Aosaikang Pharmaceutical Basic Information List
    Table 82. Jiangsu Aosaikang Pharmaceutical Description and Business Overview
    Table 83. Jiangsu Aosaikang Pharmaceutical Oxaliplatin Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Oxaliplatin Business of Jiangsu Aosaikang Pharmaceutical (2019-2024)
    Table 85. Jiangsu Aosaikang Pharmaceutical Recent Developments
    Table 86. Qilu Pharmaceutical Basic Information List
    Table 87. Qilu Pharmaceutical Description and Business Overview
    Table 88. Qilu Pharmaceutical Oxaliplatin Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Oxaliplatin Business of Qilu Pharmaceutical (2019-2024)
    Table 90. Qilu Pharmaceutical Recent Developments
    Table 91. Hisun Pharmaceutical Basic Information List
    Table 92. Hisun Pharmaceutical Description and Business Overview
    Table 93. Hisun Pharmaceutical Oxaliplatin Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Oxaliplatin Business of Hisun Pharmaceutical (2019-2024)
    Table 95. Hisun Pharmaceutical Recent Developments
    Table 96. Lunan Pharmaceutical Basic Information List
    Table 97. Lunan Pharmaceutical Description and Business Overview
    Table 98. Lunan Pharmaceutical Oxaliplatin Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Oxaliplatin Business of Lunan Pharmaceutical (2019-2024)
    Table 100. Lunan Pharmaceutical Recent Developments
    Table 101. Luoxin Basic Information List
    Table 102. Luoxin Description and Business Overview
    Table 103. Luoxin Oxaliplatin Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Oxaliplatin Business of Luoxin (2019-2024)
    Table 105. Luoxin Recent Developments
    Table 106. Halfsky Pharmacy Basic Information List
    Table 107. Halfsky Pharmacy Description and Business Overview
    Table 108. Halfsky Pharmacy Oxaliplatin Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Oxaliplatin Business of Halfsky Pharmacy (2019-2024)
    Table 110. Halfsky Pharmacy Recent Developments
    Table 111. YRPG Basic Information List
    Table 112. YRPG Description and Business Overview
    Table 113. YRPG Oxaliplatin Products, Services and Solutions
    Table 114. Revenue (US$ Million) in Oxaliplatin Business of YRPG (2019-2024)
    Table 115. YRPG Recent Developments
    Table 116. Hainan Jinrui Pharmaceutical Basic Information List
    Table 117. Hainan Jinrui Pharmaceutical Description and Business Overview
    Table 118. Hainan Jinrui Pharmaceutical Oxaliplatin Products, Services and Solutions
    Table 119. Revenue (US$ Million) in Oxaliplatin Business of Hainan Jinrui Pharmaceutical (2019-2024)
    Table 120. Hainan Jinrui Pharmaceutical Recent Developments
    Table 121. Jari Pharmaceutical Basic Information List
    Table 122. Jari Pharmaceutical Description and Business Overview
    Table 123. Jari Pharmaceutical Oxaliplatin Products, Services and Solutions
    Table 124. Revenue (US$ Million) in Oxaliplatin Business of Jari Pharmaceutical (2019-2024)
    Table 125. Jari Pharmaceutical Recent Developments
    Table 126. Chiatai Tianqing Basic Information List
    Table 127. Chiatai Tianqing Description and Business Overview
    Table 128. Chiatai Tianqing Oxaliplatin Products, Services and Solutions
    Table 129. Revenue (US$ Million) in Oxaliplatin Business of Chiatai Tianqing (2019-2024)
    Table 130. Chiatai Tianqing Recent Developments
    Table 131. Key Raw Materials Lists
    Table 132. Raw Materials Key Suppliers Lists
    Table 133. Oxaliplatin Downstream Customers
    Table 134. Oxaliplatin Distributors List
    Table 135. Research Programs/Design for This Report
    Table 136. Key Data Information from Secondary Sources
    Table 137. Key Data Information from Primary Sources
    Table 138. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Oxaliplatin Product Picture
    Figure 2. Global Oxaliplatin Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Oxaliplatin Sales Value (2019-2030) & (US$ Million)
    Figure 4. Oxaliplatin Report Years Considered
    Figure 5. Global Oxaliplatin Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Oxaliplatin Revenue in 2023
    Figure 7. Oxaliplatin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Mannitol Picture
    Figure 9. Glucose Solution Picture
    Figure 10. Lactose Solution Picture
    Figure 11. Others Picture
    Figure 12. Global Oxaliplatin Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 13. Global Oxaliplatin Sales Value Market Share by Type, 2023 & 2030
    Figure 14. Product Picture of Colorectal Cancer
    Figure 15. Product Picture of Stomach Cancer
    Figure 16. Product Picture of Ovarian Cancer
    Figure 17. Product Picture of Others
    Figure 18. Global Oxaliplatin Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 19. Global Oxaliplatin Sales Value Market Share by Application, 2023 & 2030
    Figure 20. North America Oxaliplatin Sales Value (2019-2030) & (US$ Million)
    Figure 21. North America Oxaliplatin Sales Value by Country (%), 2023 VS 2030
    Figure 22. Europe Oxaliplatin Sales Value (2019-2030) & (US$ Million)
    Figure 23. Europe Oxaliplatin Sales Value by Country (%), 2023 VS 2030
    Figure 24. Asia Pacific Oxaliplatin Sales Value (2019-2030) & (US$ Million)
    Figure 25. Asia Pacific Oxaliplatin Sales Value by Country (%), 2023 VS 2030
    Figure 26. South America Oxaliplatin Sales Value (2019-2030) & (US$ Million)
    Figure 27. South America Oxaliplatin Sales Value by Country (%), 2023 VS 2030
    Figure 28. Middle East & Africa Oxaliplatin Sales Value (2019-2030) & (US$ Million)
    Figure 29. Middle East & Africa Oxaliplatin Sales Value by Country (%), 2023 VS 2030
    Figure 30. Key Countries/Regions Oxaliplatin Sales Value (%), (2019-2030)
    Figure 31. United States Oxaliplatin Sales Value, (2019-2030) & (US$ Million)
    Figure 32. United States Oxaliplatin Sales Value by Type (%), 2023 VS 2030
    Figure 33. United States Oxaliplatin Sales Value by Application (%), 2023 VS 2030
    Figure 34. Europe Oxaliplatin Sales Value, (2019-2030) & (US$ Million)
    Figure 35. Europe Oxaliplatin Sales Value by Type (%), 2023 VS 2030
    Figure 36. Europe Oxaliplatin Sales Value by Application (%), 2023 VS 2030
    Figure 37. China Oxaliplatin Sales Value, (2019-2030) & (US$ Million)
    Figure 38. China Oxaliplatin Sales Value by Type (%), 2023 VS 2030
    Figure 39. China Oxaliplatin Sales Value by Application (%), 2023 VS 2030
    Figure 40. Japan Oxaliplatin Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Japan Oxaliplatin Sales Value by Type (%), 2023 VS 2030
    Figure 42. Japan Oxaliplatin Sales Value by Application (%), 2023 VS 2030
    Figure 43. South Korea Oxaliplatin Sales Value, (2019-2030) & (US$ Million)
    Figure 44. South Korea Oxaliplatin Sales Value by Type (%), 2023 VS 2030
    Figure 45. South Korea Oxaliplatin Sales Value by Application (%), 2023 VS 2030
    Figure 46. Southeast Asia Oxaliplatin Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Southeast Asia Oxaliplatin Sales Value by Type (%), 2023 VS 2030
    Figure 48. Southeast Asia Oxaliplatin Sales Value by Application (%), 2023 VS 2030
    Figure 49. India Oxaliplatin Sales Value, (2019-2030) & (US$ Million)
    Figure 50. India Oxaliplatin Sales Value by Type (%), 2023 VS 2030
    Figure 51. India Oxaliplatin Sales Value by Application (%), 2023 VS 2030
    Figure 52. Oxaliplatin Industrial Chain
    Figure 53. Oxaliplatin Manufacturing Cost Structure
    Figure 54. Channels of Distribution (Direct Sales, and Distribution)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS